nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Induration—Etoposide—sarcoma	0.0262	0.0262	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Mitoxantrone—sarcoma	0.0246	0.0246	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Etoposide—sarcoma	0.0204	0.0204	CcSEcCtD
Ceftizoxime—Injection site pain—Thiotepa—sarcoma	0.02	0.02	CcSEcCtD
Ceftizoxime—Numbness—Vincristine—sarcoma	0.0175	0.0175	CcSEcCtD
Ceftizoxime—Sensory loss—Vincristine—sarcoma	0.0167	0.0167	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Epirubicin—sarcoma	0.016	0.016	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Dactinomycin—sarcoma	0.0152	0.0152	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Doxorubicin—sarcoma	0.0148	0.0148	CcSEcCtD
Ceftizoxime—Numbness—Etoposide—sarcoma	0.0142	0.0142	CcSEcCtD
Ceftizoxime—Phlebitis—Dactinomycin—sarcoma	0.0137	0.0137	CcSEcCtD
Ceftizoxime—Sensory loss—Etoposide—sarcoma	0.0135	0.0135	CcSEcCtD
Ceftizoxime—Cellulitis—Etoposide—sarcoma	0.0129	0.0129	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Epirubicin—sarcoma	0.0128	0.0128	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Doxorubicin—sarcoma	0.0119	0.0119	CcSEcCtD
Ceftizoxime—Phlebitis—Mitoxantrone—sarcoma	0.0119	0.0119	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Epirubicin—sarcoma	0.0113	0.0113	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.0106	0.0106	CcSEcCtD
Ceftizoxime—Thrombocytosis—Epirubicin—sarcoma	0.0106	0.0106	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Doxorubicin—sarcoma	0.0105	0.0105	CcSEcCtD
Ceftizoxime—Phlebitis—Etoposide—sarcoma	0.00988	0.00988	CcSEcCtD
Ceftizoxime—Thrombocytosis—Doxorubicin—sarcoma	0.00978	0.00978	CcSEcCtD
Ceftizoxime—Pancytopenia—Thiotepa—sarcoma	0.00973	0.00973	CcSEcCtD
Ceftizoxime—Pancytopenia—Dactinomycin—sarcoma	0.00966	0.00966	CcSEcCtD
Ceftizoxime—Neutropenia—Dactinomycin—sarcoma	0.00951	0.00951	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00899	0.00899	CcSEcCtD
Ceftizoxime—Pancytopenia—Vincristine—sarcoma	0.00863	0.00863	CcSEcCtD
Ceftizoxime—Agranulocytosis—Thiotepa—sarcoma	0.00852	0.00852	CcSEcCtD
Ceftizoxime—Neutropenia—Vincristine—sarcoma	0.0085	0.0085	CcSEcCtD
Ceftizoxime—Agranulocytosis—Dactinomycin—sarcoma	0.00846	0.00846	CcSEcCtD
Ceftizoxime—Pancytopenia—Mitoxantrone—sarcoma	0.0084	0.0084	CcSEcCtD
Ceftizoxime—Neutropenia—Mitoxantrone—sarcoma	0.00827	0.00827	CcSEcCtD
Ceftizoxime—Haemoglobin—Thiotepa—sarcoma	0.00824	0.00824	CcSEcCtD
Ceftizoxime—Haemorrhage—Thiotepa—sarcoma	0.0082	0.0082	CcSEcCtD
Ceftizoxime—Injection site pain—Epirubicin—sarcoma	0.00805	0.00805	CcSEcCtD
Ceftizoxime—Erythema multiforme—Dactinomycin—sarcoma	0.0077	0.0077	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00767	0.00767	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—sarcoma	0.00745	0.00745	CcSEcCtD
Ceftizoxime—Agranulocytosis—Mitoxantrone—sarcoma	0.00736	0.00736	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Vincristine—sarcoma	0.00724	0.00724	CcSEcCtD
Ceftizoxime—Cellulitis—Epirubicin—sarcoma	0.00723	0.00723	CcSEcCtD
Ceftizoxime—Haemoglobin—Mitoxantrone—sarcoma	0.00712	0.00712	CcSEcCtD
Ceftizoxime—Haemorrhage—Mitoxantrone—sarcoma	0.00708	0.00708	CcSEcCtD
Ceftizoxime—Pancytopenia—Etoposide—sarcoma	0.00699	0.00699	CcSEcCtD
Ceftizoxime—Neutropenia—Etoposide—sarcoma	0.00688	0.00688	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—sarcoma	0.00669	0.00669	CcSEcCtD
Ceftizoxime—Anaemia—Thiotepa—sarcoma	0.0066	0.0066	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Epirubicin—sarcoma	0.00658	0.00658	CcSEcCtD
Ceftizoxime—Anaemia—Dactinomycin—sarcoma	0.00655	0.00655	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00651	0.00651	CcSEcCtD
Ceftizoxime—Leukopenia—Thiotepa—sarcoma	0.00639	0.00639	CcSEcCtD
Ceftizoxime—Leukopenia—Dactinomycin—sarcoma	0.00634	0.00634	CcSEcCtD
Ceftizoxime—Vaginal infection—Epirubicin—sarcoma	0.00621	0.00621	CcSEcCtD
Ceftizoxime—Convulsion—Thiotepa—sarcoma	0.00619	0.00619	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Epirubicin—sarcoma	0.00617	0.00617	CcSEcCtD
Ceftizoxime—Agranulocytosis—Etoposide—sarcoma	0.00612	0.00612	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—sarcoma	0.00608	0.00608	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Etoposide—sarcoma	0.00586	0.00586	CcSEcCtD
Ceftizoxime—Anaemia—Vincristine—sarcoma	0.00585	0.00585	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—sarcoma	0.00574	0.00574	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—sarcoma	0.00571	0.00571	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Thiotepa—sarcoma	0.0057	0.0057	CcSEcCtD
Ceftizoxime—Anaemia—Mitoxantrone—sarcoma	0.0057	0.0057	CcSEcCtD
Ceftizoxime—Leukopenia—Vincristine—sarcoma	0.00567	0.00567	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Dactinomycin—sarcoma	0.00566	0.00566	CcSEcCtD
Ceftizoxime—Erythema multiforme—Etoposide—sarcoma	0.00557	0.00557	CcSEcCtD
Ceftizoxime—Phlebitis—Epirubicin—sarcoma	0.00554	0.00554	CcSEcCtD
Ceftizoxime—Leukopenia—Mitoxantrone—sarcoma	0.00552	0.00552	CcSEcCtD
Ceftizoxime—Convulsion—Vincristine—sarcoma	0.00548	0.00548	CcSEcCtD
Ceftizoxime—Convulsion—Mitoxantrone—sarcoma	0.00534	0.00534	CcSEcCtD
Ceftizoxime—Paraesthesia—Thiotepa—sarcoma	0.00523	0.00523	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Vincristine—sarcoma	0.00517	0.00517	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—sarcoma	0.00513	0.00513	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Vincristine—sarcoma	0.00506	0.00506	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Mitoxantrone—sarcoma	0.00503	0.00503	CcSEcCtD
Ceftizoxime—Pain—Thiotepa—sarcoma	0.00498	0.00498	CcSEcCtD
Ceftizoxime—Pain—Dactinomycin—sarcoma	0.00494	0.00494	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Mitoxantrone—sarcoma	0.00493	0.00493	CcSEcCtD
Ceftizoxime—Anaemia—Etoposide—sarcoma	0.00474	0.00474	CcSEcCtD
Ceftizoxime—Paraesthesia—Vincristine—sarcoma	0.00464	0.00464	CcSEcCtD
Ceftizoxime—Body temperature increased—Thiotepa—sarcoma	0.00461	0.00461	CcSEcCtD
Ceftizoxime—Leukopenia—Etoposide—sarcoma	0.00459	0.00459	CcSEcCtD
Ceftizoxime—Body temperature increased—Dactinomycin—sarcoma	0.00457	0.00457	CcSEcCtD
Ceftizoxime—Paraesthesia—Mitoxantrone—sarcoma	0.00452	0.00452	CcSEcCtD
Ceftizoxime—Convulsion—Etoposide—sarcoma	0.00444	0.00444	CcSEcCtD
Ceftizoxime—Pain—Vincristine—sarcoma	0.00442	0.00442	CcSEcCtD
Ceftizoxime—Pain—Mitoxantrone—sarcoma	0.0043	0.0043	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.0043	0.0043	CcSEcCtD
Ceftizoxime—Hypersensitivity—Thiotepa—sarcoma	0.00429	0.00429	CcSEcCtD
Ceftizoxime—Hypersensitivity—Dactinomycin—sarcoma	0.00426	0.00426	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Etoposide—sarcoma	0.00419	0.00419	CcSEcCtD
Ceftizoxime—Pruritus—Thiotepa—sarcoma	0.00412	0.00412	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Etoposide—sarcoma	0.0041	0.0041	CcSEcCtD
Ceftizoxime—Eosinophilia—Epirubicin—sarcoma	0.00408	0.00408	CcSEcCtD
Ceftizoxime—Body temperature increased—Vincristine—sarcoma	0.00408	0.00408	CcSEcCtD
Ceftizoxime—Diarrhoea—Thiotepa—sarcoma	0.00399	0.00399	CcSEcCtD
Ceftizoxime—Body temperature increased—Mitoxantrone—sarcoma	0.00398	0.00398	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00398	0.00398	CcSEcCtD
Ceftizoxime—Diarrhoea—Dactinomycin—sarcoma	0.00396	0.00396	CcSEcCtD
Ceftizoxime—Pancytopenia—Epirubicin—sarcoma	0.00392	0.00392	CcSEcCtD
Ceftizoxime—Neutropenia—Epirubicin—sarcoma	0.00386	0.00386	CcSEcCtD
Ceftizoxime—Hypersensitivity—Vincristine—sarcoma	0.00381	0.00381	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—sarcoma	0.00378	0.00378	CcSEcCtD
Ceftizoxime—Paraesthesia—Etoposide—sarcoma	0.00376	0.00376	CcSEcCtD
Ceftizoxime—Hypersensitivity—Mitoxantrone—sarcoma	0.00371	0.00371	CcSEcCtD
Ceftizoxime—Vomiting—Thiotepa—sarcoma	0.0037	0.0037	CcSEcCtD
Ceftizoxime—Vomiting—Dactinomycin—sarcoma	0.00368	0.00368	CcSEcCtD
Ceftizoxime—Rash—Thiotepa—sarcoma	0.00367	0.00367	CcSEcCtD
Ceftizoxime—Dermatitis—Thiotepa—sarcoma	0.00367	0.00367	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00365	0.00365	CcSEcCtD
Ceftizoxime—Rash—Dactinomycin—sarcoma	0.00365	0.00365	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—sarcoma	0.00362	0.00362	CcSEcCtD
Ceftizoxime—Pain—Etoposide—sarcoma	0.00358	0.00358	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—sarcoma	0.00357	0.00357	CcSEcCtD
Ceftizoxime—Diarrhoea—Vincristine—sarcoma	0.00353	0.00353	CcSEcCtD
Ceftizoxime—Nausea—Thiotepa—sarcoma	0.00346	0.00346	CcSEcCtD
Ceftizoxime—Diarrhoea—Mitoxantrone—sarcoma	0.00344	0.00344	CcSEcCtD
Ceftizoxime—Nausea—Dactinomycin—sarcoma	0.00343	0.00343	CcSEcCtD
Ceftizoxime—Agranulocytosis—Epirubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00337	0.00337	CcSEcCtD
Ceftizoxime—Haemoglobin—Epirubicin—sarcoma	0.00332	0.00332	CcSEcCtD
Ceftizoxime—Body temperature increased—Etoposide—sarcoma	0.00331	0.00331	CcSEcCtD
Ceftizoxime—Haemorrhage—Epirubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Epirubicin—sarcoma	0.00329	0.00329	CcSEcCtD
Ceftizoxime—Vomiting—Vincristine—sarcoma	0.00328	0.00328	CcSEcCtD
Ceftizoxime—Rash—Vincristine—sarcoma	0.00326	0.00326	CcSEcCtD
Ceftizoxime—Dermatitis—Vincristine—sarcoma	0.00325	0.00325	CcSEcCtD
Ceftizoxime—Vomiting—Mitoxantrone—sarcoma	0.0032	0.0032	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Ceftizoxime—Rash—Mitoxantrone—sarcoma	0.00317	0.00317	CcSEcCtD
Ceftizoxime—Dermatitis—Mitoxantrone—sarcoma	0.00317	0.00317	CcSEcCtD
Ceftizoxime—Erythema multiforme—Epirubicin—sarcoma	0.00312	0.00312	CcSEcCtD
Ceftizoxime—Hypersensitivity—Etoposide—sarcoma	0.00308	0.00308	CcSEcCtD
Ceftizoxime—Haemoglobin—Doxorubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Ceftizoxime—Nausea—Vincristine—sarcoma	0.00307	0.00307	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Ceftizoxime—Nausea—Mitoxantrone—sarcoma	0.00299	0.00299	CcSEcCtD
Ceftizoxime—Pruritus—Etoposide—sarcoma	0.00296	0.00296	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—sarcoma	0.00289	0.00289	CcSEcCtD
Ceftizoxime—Diarrhoea—Etoposide—sarcoma	0.00286	0.00286	CcSEcCtD
Ceftizoxime—Vomiting—Etoposide—sarcoma	0.00266	0.00266	CcSEcCtD
Ceftizoxime—Anaemia—Epirubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Ceftizoxime—Rash—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Ceftizoxime—Dermatitis—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Ceftizoxime—Leukopenia—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Ceftizoxime—Convulsion—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Ceftizoxime—Nausea—Etoposide—sarcoma	0.00249	0.00249	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Epirubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Epirubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Ceftizoxime—Paraesthesia—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Pain—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Ceftizoxime—Body temperature increased—Epirubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Ceftizoxime—Hypersensitivity—Epirubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Ceftizoxime—Pruritus—Epirubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Ceftizoxime—Diarrhoea—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Ceftizoxime—Vomiting—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Ceftizoxime—Rash—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Ceftizoxime—Dermatitis—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Ceftizoxime—Nausea—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
